Where is myDNA located?

myDNA is headquartered in South Yarra, Australia.

How many employees does myDNA have?

As of Sep 30, 2026, the latest employee count at myDNA is 45.

Where does myDNA rank among its competitors?

myDNA ranks 195th amongst 360 active competitors, of which 122 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was GenSight Biologics, which secured $1.96M in Mar, 2026.

Who are the top competitors of myDNA?

myDNA's top competitors include MedGenome, Geneoscopy and Caris Life Sciences. Among them, GenSight Biologics secured the most recent funding round in March, 2026.

myDNA - 2026 Company Profile, Team, Funding & Competitors

myDNA is a funded company based in South Yarra (Australia), founded in 2007 by Leslie Sheffield. It operates as a Provider of personalized genomics for precision medicine. The company has 360 active competitors, including 122 funded and 78 that have exited. Its top competitors include companies like MedGenome, Geneoscopy and Caris Life Sciences.

Company Details

Provider of personalized genomics for precision medicine. The myDNA test, which can be ordered online, or purchased from pharmacies across Australia starts with sample collection using cheek swabs. The sequence data is analyzed and interpreted by experts, who then create a highly personalized report to be shared with the customer and their designated physician. The physician can then plan treatment guided by the genome profile of the patient. The company offers its services through its website, as well as through partnerships with pharmacy chains like GuildLink in Australia.

Website: www.mydna.life/
Social
Email ID: *****@mydna.life

Key Metrics

Founded Year

2007

Location

South Yarra, Australia

Stage

Funding Raised

Investors

BLANCAP INVESTMENTS

Ranked

195^th among 360 active competitors

Employee Count

45 as on Sep 30, 2026

Investment & Acquisitions

Australian Life Tech

Similar Companies

MedGenome & 507 more

View myDNA's full profile

myDNA is a funded company. myDNA has 1 institutional investor.

View details of myDNA's funding rounds and investors

The founders of myDNA is Leslie Sheffield.

Here are the details of myDNA's key team members:

Leslie Sheffield: Founder of myDNA.
Contact Info: 2 email addresses

View details of myDNA's Founder profiles and Board Members

myDNA's employee count trend

myDNA has 45 employees as of Sep 26. Here is myDNA's employee count trend over the years:

Uncover myDNA's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of myDNA include MedGenome, Geneoscopy and Caris Life Sciences. Here is the list of Top 10 competitors of myDNA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MedGenome 2013, Bengaluru (India), Series E	Provider of DNA sequencing, bioinformatics, and multiomics services	$264M	Novo Holdings, Peak XV Partners & 30 others	70/100
2nd	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	67/100
3rd	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	66/100
4th	Intellia Therapeutics 2014, Cambridge (United States), Public	Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases	$85M	Atlas Venture, Novartis & 10 others	66/100
5th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
6th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Gilde Healthcare, Advent Life Sciences & 11 others	62/100
7th	GenSight Biologics 2011, Paris (France), Public	Developer of viral vector-based gene therapies for retinal neurodegenerative diseases	$76.6M	Perceptive Advisors, Fidelity Investments ... & 17 others	61/100
8th	Repare Therapeutics 2016, Montreal (Canada), Acquired	Developer of targeted therapies to address the genetic alterations associated with selected tumors	$166M	Versant Ventures, Cowen & 13 others	60/100
9th	Dicerna Pharmaceuticals 2007, Lexington (United States), Acquired	Developer of drugs by using RNA interference technology platform	$106M	RA Capital Management, Domain Associates ... & 18 others	60/100
10th	Seres Therapeutics 2010, Cambridge (United States), Public	Developer of microbiome therapeutics to treat a wide range of diseases	$134M	Flagship Pioneering, Mayo Clinic Business Accelerator ... & 8 others	60/100
195th	myDNA 2007, South Yarra (Australia), Funding Raised	Provider of personalized genomics for precision medicine	-	BLANCAP INVESTMENTS	30/100